ARCHANA BARRY: Open Payments
NPI 1609878545 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 31 payments from 12 companies in 2025. Trend: 2023 $1,072 · 2024 $363 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| ABBVIE INC. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Corium, LLC | 4 | $65 |
| Tris Pharma Inc | 3 | $59 |
| Lundbeck LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Alkermes, Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: INGREZZA, COBENFY, VRAYLAR, CAPLYTA, Azstarys, Dyanavel XR, ABILIFY MAINTENA, REXULTI.
Industry payments across IN — which companies pay providers there.
